Odisha Pharma Summit 2025 to Explore Opportunities in Pharmaceutical Sector on December 16

The Odisha government is set to host the Odisha Pharma Summit 2025 on December 16. This event aims to unite stakeholders from the pharmaceutical and medical devices industries to explore new opportunities. Chief Minister Mohan Charan Majhi will inaugurate the programme. An official mentioned that the state will introduce the Odisha Pharmaceutical and Medical Devices Policy 2025 during this event.

The new policy is designed to attract investments, enhance business ease, and generate large-scale employment in the life sciences sector. Additionally, the government plans to announce the development of a Pharmaceutical Park and a Medical Devices Park. These initiatives aim to bolster the state’s healthcare manufacturing infrastructure and promote industry growth.

Focus on Industry Growth
Industries Minister Sampad Chandra Swain stated, “Odisha welcomes all pharma, medical devices & related sector industries, investors, and thought leaders to join us at this summit. We are committed to building a strong, future-ready ecosystem that supports growth, innovation, and global competitiveness.” The summit will also feature the signing of MoUs between the government and leading companies.

This collaboration marks a significant step towards enhancing the state’s pharmaceutical and medical devices ecosystem. The government encourages healthcare and industry enthusiasts to participate in this initiative, which aims to shape the future of the sector in Odisha.

The event’s agenda includes discussions on investment opportunities and strategies for improving business operations in the life sciences field. By bringing together industry leaders and investors, Odisha aims to position itself as a hub for pharmaceutical and medical device manufacturing.

Related Posts

Odisha Receives Investment Commitments Worth ₹7,043 Cr in Pharma & Medtech

Odisha has received investment commitments worth ₹7,043 crore across the pharmaceutical and medical technology sectors, marking a major step in strengthening the state’s position as an emerging healthcare manufacturing hub.…

Cough Syrup Racket Busted: Kingpin Shubham Jaiswal skips ED summons; Here’s what happens next

Mastermind of India’s massive codeine cough syrup racket skips ED summons- what’s next for Shubham Jaiswal? With arrest warrants, Red Corner Notices, and cross-border drug links, the investigation could expose…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Odisha Receives Investment Commitments Worth ₹7,043 Cr in Pharma & Medtech

Odisha Receives Investment Commitments Worth ₹7,043 Cr in Pharma & Medtech

Cough Syrup Racket Busted: Kingpin Shubham Jaiswal skips ED summons; Here’s what happens next

Cough Syrup Racket Busted: Kingpin Shubham Jaiswal skips ED summons; Here’s what happens next

Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore

Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore

Aytu BioPharma launches depression drug EXXUA in U.S. market

Aytu BioPharma launches depression drug EXXUA in U.S. market

Delhi govt carries out 27 raids against fake medicine

Delhi govt carries out 27 raids against fake medicine

Odisha Pharma Summit 2025 to Explore Opportunities in Pharmaceutical Sector on December 16

Odisha Pharma Summit 2025 to Explore Opportunities in Pharmaceutical Sector on December 16